Top Markets
Coin of the day
InVitro International InVitro International

InVitro International

IVRO
Rank in Stocks #38273
Established in 1985 and headquartered in Placentia, California, InVitro... Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining chemical corrosiveness. Beyond product sales, the company delivers tailored technological support for the implementation and use of the Irritection system, alongside offering independent laboratory services for irritation and corrosion assessments. Their solutions are predominantly adopted by manufacturers involved in producing surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials.
Share Price
$0.049
Last synced: 2026-08-13
Market Cap
$1.09M
Change (1 day)
-15.50%
Change (1 year)
-36.20%
Country
US
Trade InVitro International (IVRO)

Category

EPS for InVitro International (IVRO)
EPS as of 2026 TTM: 0
According to InVitro International latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for InVitro International from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors